Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

FOI 0381 2019/20: Corporate Governance

Published: December 31, 2019

Freedom of Information Request: 0381 2019/20

Please could you provide me with the following information:

  1. The post title of the most senior employee in the organisation (other than the Chief Executive) with responsibility for corporate governance issues (e.g. Director of Corporate Affairs, Trust Secretary, Company Secretary or equivalent); Director of Corporate Affairs
  2. The job / role description of the employee identified in response to question 1 above; Please see attached Director of Corporate Affairs Job Description
  3. A list of the posts reporting, directly or indirectly, to the employee identified in response to question 1 above, including the job / role descriptions for each of these posts;

Director of Corporate Affairs/Foundation Secretary

    1. Deputy Foundation Secretary/DPO (8c) Band 8c JD – Deputy Foundation Secretary

                                          i.    IG Lead (8a) Band 8a JD – IG Lead

1.    IG Manager (7) Band 7 JD – IG Manager

a.    IG officer (5) band 5 JD – IG Officer

                                                                                          i.    IG Assistant (3) Band 3 JD – IG Assistant

                                         ii.    Risk Lead (8a) band 8a JD – Corporate Risk Lead

1.    Corporate Compliance Manager (7) Band 7 JD – Corporate Compliance Manager

a.    Policy Assurance Officer (5) Band 5 JD – Policy Assurance Officer

b.    Corporate Assurance Assistant (shared with Risk Manager) (3) Band 3 JD- Corporate Assurance Assistant

2.    Risk Manager (7) band 7 JD – Corporate Risk Manager

a.    Corporate Assurance Assistant (shared with Corporate Compliance  Manager) (3) Band 3 JD- Corporate Assurance Assistant

                                        iii.    Corporate Affairs Officer (6)/ Corporate Affairs Governor Liaison Officer (6) Band 6 JD – Corporate Affairs Officer Band 6 JD – Corporate Affairs Governor Liaison Officer

1.    Corporate Affairs Administrator Band 3 JD – Corporate Affairs Administrator

Please see attached Job Description for the above roles

4. A list of the Board Committees for which the Trust Secretariat (or equivalent) is responsible for providing direct secretariat support; Board of Directors, Board of Directors Clinical Quality Committee, Executive Appointments and Remuneration Committee, Audit Committee, NED Remuneration & Nominations Committee and Investment Committee.

5. The post title of the most senior employee in the organisation (other than the Chief Executive) responsible for (i) the Board Assurance Framework, and (ii) the Corporate Risk Register; Director of Corporate Affairs

6. The post title of the most senior employee in the organisation (other than the Chief Executive) responsible for overseeing and managing the Freedom of Information function; Director of Corporate Affairs

7. The post title of the most senior employee in the organisation (other than the Chief Executive) responsible for Freedom to Speak Up (i.e. the person who has senior responsibility for the FTSU function) FTSU Guardian and Director of Corporate Affairs

8. The post title of the most senior employee in the organisation (other than the Chief Executive) responsible for complaints. Chief Nurse

FOI 0360 2019/20: Tonsillectomy & Adenotonsilectomy Procedures

Published: December 31, 2019

Freedom of Information Request: 0360 2019/20

  1. How many Tonsillectomy & Adenotonsilectomy procedures were performed in the year 2018?
  1. How many Tonsillectomy & Adenotonsilectomy procedures were performed in the year 2019 Year to date?
  1. If possible I would also like to know the split between Paediatric and Adult procedures?

QEHB:

Tonsillectomy – QE Tonsillectomy with Adenoidectomy – QE
2018 2019 2018 2019
Adult 216 108 Adult 0 2
Paeds 2 1 Paeds 0 0
Total 218 109 Total 0 2

 

HGS: Please note that this information has been split by financial year

Row Labels 2018-19 2019-20 Grand Total
Paediatric 210 56 266
Adult 146 32 178
Grand Total 356 88 444

FOI 0535 2019/20: Deaths caused by Sepsis

Published: December 31, 2019

Freedom of Information Request: 0535 2019/20

University Hospitals Birmingham NHS Foundation Trust (UHB) completed a merger by acquisition of Heart of England NHS Foundation Trust (HEFT) on 1st April 2018.  Due to historical differences in data collection/reporting across UHB and the former Heart of England NHS Foundation Trust this response has been provided by hospital site.

I am writing to you under the Freedom of Information Act 2000.

  1. Please can you supply me with a list of every patient death by sepsis over the last 10 calendar years (removing any person information that might identify the patient if necessary to comply with data protection laws).

Heartlands, Good Hope, and Solihull Hospitals (all available data):

Month Deaths Month Deaths Month Deaths
Mar-13 29 Jul-15 23 Oct-17 27
Apr-13 22 Aug-15 20 Nov-17 35
May-13 24 Sep-15 35 Dec-17 33
Jun-13 21 Oct-15 35 Jan-18 51
Jul-13 26 Nov-15 29 Feb-18 29
Aug-13 10 Dec-15 29 Mar-18 41
Sep-13 26 Jan-16 43 Apr-18 40
Oct-13 33 Feb-16 43 May-18 33
Nov-13 27 Mar-16 41 Jun-18 23
Dec-13 40 Apr-16 37 Jul-18 22
Jan-14 29 May-16 29 Aug-18 25
Feb-14 29 Jun-16 30 Sep-18 19
Mar-14 35 Jul-16 27 Oct-18 20
Apr-14 32 Aug-16 27 Nov-18 20
May-14 24 Sep-16 33 Dec-18 26
Jun-14 18 Oct-16 31 Jan-19 27
Jul-14 27 Nov-16 40 Feb-19 32
Aug-14 33 Dec-16 38 Mar-19 23
Sep-14 21 Jan-17 36 Apr-19 22
Oct-14 33 Feb-17 33 May-19 30
Nov-14 33 Mar-17 30 Jun-19 14
Dec-14 44 Apr-17 27 Jul-19 21
Jan-15 41 May-17 41 Aug-19 20
Feb-15 46 Jun-17 17 Sep-19 20
Mar-15 40 Jul-17 28 Oct-19 18
Apr-15 28 Aug-17 36 Nov-19 18
May-15 31 Sep-17 23 Dec-19 18
Jun-15 24

Total: 2,394

Queen Elizabeth Hospital Birmingham:

Month Deaths Month Deaths Month Deaths
Nov-09 10 Mar-13 14 Sep-16 5
Dec-09 9 Apr-13 9 Oct-16 8
Jan-10 11 May-13 6 Nov-16 17
Feb-10 7 Jun-13 6 Dec-16 21
Mar-10 5 Jul-13 10 Jan-17 24
Apr-10 10 Aug-13 11 Feb-17 14
May-10 8 Sep-13 13 Mar-17 19
Jun-10 12 Oct-13 5 Apr-17 14
Jul-10 12 Nov-13 9 May-17 13
Aug-10 11 Dec-13 14 Jun-17 9
Sep-10 4 Jan-14 11 Jul-17 16
Oct-10 6 Feb-14 15 Aug-17 11
Nov-10 8 Mar-14 22 Sep-17 13
Dec-10 18 Apr-14 20 Oct-17 15
Jan-11 12 May-14 16 Nov-17 12
Feb-11 10 Jun-14 16 Dec-17 14
Mar-11 5 Jul-14 7 Jan-18 12
Apr-11 7 Aug-14 11 Feb-18 10
May-11 5 Sep-14 12 Mar-18 20
Jun-11 7 Oct-14 11 Apr-18 13
Jul-11 17 Dec-14 2 May-18 15
Aug-11 4 Jan-15 18 Jun-18 10
Sep-11 6 Feb-15 10 Jul-18 17
Oct-11 5 Mar-15 4 Aug-18 14
Nov-11 4 Apr-15 15 Sep-18 16
Dec-11 4 May-15 13 Oct-18 14
Jan-12 12 Jun-15 13 Nov-18 11
Feb-12 12 Jul-15 12 Dec-18 11
Mar-12 5 Aug-15 7 Jan-19 12
Apr-12 4 Sep-15 9 Feb-19 10
May-12 16 Oct-15 1 Mar-19 11
Jun-12 8 Dec-15 2 Apr-19 14
Jul-12 8 Jan-16 20 May-19 14
Aug-12 11 Feb-16 17 Jun-19 5
Sep-12 9 Mar-16 18 Jul-19 9
Oct-12 11 Apr-16 14 Aug-19 13
Nov-12 11 May-16 10 Sep-19 12
Dec-12 16 Jun-16 11 Oct-19 15
Jan-13 14 Jul-16 10 Nov-19 12
Feb-13 12 Aug-16 22 Dec-19 5

Total: 1,352

The Trust does hold all the information you have requested below, however we are withholding this information for the following reasons.

a. If possible, this should include any internal investigation carried out by the trust, or

b. any notes that give information on what treatment the patient was given before they died.

The Trust does hold the information you have requested, however we are withholding it under Section 40 (2) (Personal Information) of the Freedom of information Act (2000). If we were to gather this information by retrieving information from individual patient records we would be in breach of the second data protection principle “Personal information must be processed for limited purpose”.

We would need to review individual patient records to determine whether an internal investigation took place, which would also breach this principle.

Section 40 (2) is an absolute exemption meaning there is no requirement to consider the public interest when disclosing this information.

FOI 0337 2019/20: Synagis (palivizumab) Treatments

Published: December 31, 2019

Freedom of Information Request: 0337 2019/20

  1. Please complete the number of patients treated with Synagis (palivizumab) in the grid below. Please note that the total number of patients (A to E) in each column must add to total patients in the last row in the corresponding column.
Patients / babies treated with Synagis in the last three years Total number patients treated with Synagis (Palivizumab)

April 2018 to March 2019

Total number patients treated with Synagis (Palivizumab)

April 2017 to March 2018

Total number patients treated with Synagis (Palivizumab)

April 2016 to March 2017

A.   Total number of patients with BPD / CLD diagnosis      
B.   Total number of patients with CHD diagnosis      
C.   Total number of <29wga (without BPD/CHD diagnosis)      
D.   Total number of multiple births immunised (without BPD/CHD diagnosis)      
E.    Other patients (please specify:

_____________________________________)

     
Total number of patients[1] 42 43 42

[1] Total patients treated with Synagis in each of the last 3 years

BPD: bronchopulmonary dysplasia; CLD: Chronic Lung Disease; CHD: congenital heart disease

 

2. Please advise which OPCS codes are used within your Trust to code respiratory syncytial virus (RSV) prophylaxis treatment.

Code Description Used within Trust to indicate patient received RSV prophylaxis treatment? Yes/No
X86.5 Respiratory syncytial virus prevention drugs band 1 Yes
X44.2 Intramuscular injection of vaccine Yes
Other (if not listed above, please specify code(s)): We also use the ICD-10 code Z29.2

 

3. If your Trust does not provide RSV prophylaxis treatment and you refer your patients to another Trust, please state to which Trust(s) patients are referred. Not Applicable

FOI 0527 2019/20: Deaths related to Haemonetics Plasma Devices

Published: December 27, 2019

Freedom of Information Request: 0527 2019/20

Please can you tell me how many deaths have been reviewed by the trust or reported to a coroner in the past 10 calendar years where the hospital used a Haemonetics plasma device (any model number) on the patient before they died.

Where the death was investigated please can you send me the report (redacted to remove personal details if necessary) and include the age, gender and diagnosis of the patient. If the death was reported to the coroner please include a copy of their report.

The Trust has no record of any Haemonetics plasma devices (any model number) being in use in the past 10 years. Therefore, the request detailed above is not applicable to the Trust.

FOI 0414 2019/20: Patient Choice and Discharge Policies

Published: December 24, 2019

Freedom of Information Request: 0414 2019/20

Could I please request the following documents please?

UHB Patient Choice Policy and Practice 2009

We do not have a policy archived under this name

UHB Discharge Policy 2010

Please see attached document Operational Procedure for Discharge Lounge QEH v4

FOI 0542 2019/20: Agreements with Credit Agency & Home Office – Immigration

Published: December 24, 2019

Freedom of Information Request: 0542 2019/20

  1. Does this NHS Trust have, or has it ever had, an agreement with Experian, or any other credit agency, to share data? No
  2. If yes, please provide all such agreement documents. I would find it acceptable if you need to redact financial or personal information Not Applicable
  3. Are there, or have there ever been, any service-level agreements in place between this NHS Trust and the Home Office Immigration Enforcement to share data? No
  4. If yes, please provide all such SLAs. I would find it acceptable if you need to redact financial or personal information. Not Applicable

FOI 0546 2019/20: Secondary VAT Re-Reviews 18/19

Published: December 24, 2019

Freedom of Information Request: 0546 2019/20

Under the FOI act, could i please request the below information with regards to the trusts secondary VAT re-reviews in 18/19:

Did the trust undertake a secondary VAT re-review for the financial year 18/19?
By this, I am referring to a re-review of the original VAT review undertaken by the trust’s incumbent VAT supplier.

The Trust did not undertake a VAT re-review in 2018/19, as it was deemed unnecessary.

If so, please provide the following information:
• Name of the third party providing the secondary VAT re-review:
Not Applicable
• Total amount of VAT recovered: Not Applicable
• Total amount invoiced by the third party for the re-review: Not Applicable

FOI 0533 2019/20: Follow Up to 0483

Published: December 24, 2019

Freedom of Information Request: 0533 2019/20

Many thanks for your reply to my FOI request

Would you be able to supply a breakdown of procedures per year for Q2

Eg

Robotic urology procedures 2013

Robotic urology procedures 2014 etc

General surgery procedures 2013…etc

Robotic Urology Procedures:

2014: 44

2015: 35

2019: 10

Robotic General Surgery Procedures:

2014: 26

2015: 17

2018: 1

Robotic Colorectal Surgery Procedures:

2015: 2

FOI 0521 2019/20: Computer Numbers and Windows Upgrade

Published: December 24, 2019

Freedom of Information Request: 0521 2019/20

  1. How many computers do you have in your organisation? Circa 15000 PCs across the Trust
  2. Of these computers, how many are running WindowsXP? 11
  3. Of these computers, how many are running Windows 7? Approx. 14000 are running Windows 7 across UHB
  4. Of these computers, how many are running non-Microsoft operating systems? None
  5. Do you expect to have all of your machines with Microsoft operating systems to be running Windows 10 before the Windows 7 end of support date (14 January 2020)? No
  6. If not, how many do you expect to not be running Windows 10? Approx. 14000 (however we do have an extension to January 2021)

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.

Accessibility
Close Close